In the therapeutic model, upon animal sacrifice, the tumor masses were excised and subjected to qRT-PCR analysis of the human and mouse genes in order to assess the effects of the RGZ and MTT in vivo treatment on the CXCL12/CXCR4/CXCR7 axis and tumor vascularization. This evidence concerns the gene CXCR4 and neoplasm.